BASTIDE LE CONFORT 23.800 € (+1,06 %) JCDECAUX 18.920 € (-0,73 %) VETOQUINOL 79.000 € (0,00 %) REWORLD MEDIA 1.574 € (+3,01 %) ALSTOM 24.400 € (+2,43 %) 
AMG 34.540 € (+4,67 %) ALTEN 52.850 € (+0,57 %) ELIS 24.600 € (+0,57 %) PROSUS 41.470 € (+4,45 %) ASML HOLDING 1 211.600 € (+0,83 %) ING GROEP N.V. 22.315 € (+2,48 %) MASTRAD 0.007 € (+13,33 %) ESSILORLUXOTTICA 194.650 € (+0,99 %) PERNOD RICARD 63.580 € (+1,08 %) 
DSM FIRMENICH AG 60.160 € (+2,07 %) TIKEHAU CAPITAL 16.000 € (+3,49 %) HERMES INTL 1 668.500 € (+1,15 %) AKZO NOBEL 50.200 € (+2,57 %) AHOLD DEL 40.230 € (-0,74 %) GECINA 66.200 € (-0,15 %) NN GROUP 66.680 € (+1,62 %) 
SHELL PLC 39.690 € (-0,59 %) UNILEVER 52.710 € (+0,29 %) BE SEMICONDUCTOR 185.500 € (+0,76 %) CAPGEMINI 97.260 € (+0,93 %) UMG 15.665 € (+1,29 %) AXA 38.100 € (+0,53 %) ENGIE 27.130 € (+1,61 %) SANOFI 80.060 € (+2,94 %) ASM INTERNATIONAL 702.800 € (+3,26 %) RELX 27.900 € (-0,92 %) KAUFMAN ET BROAD 29.100 € (+0,69 %) ID LOGISTICS GROUP 324.500 € (+1,56 %) AIRBUS 168.460 € (+2,37 %) ADYEN 906.500 € (+2,03 %) EUROPLASMA 0.023 € (+21,05 %) CATANA GROUP 2.250 € (-0,66 %) VALLOUREC 21.000 € (+4,01 %) NANOBIOTIX 26.550 € (+4,53 %) SAFRAN 288.100 € (+2,13 %) LHYFE 2.920 € (+5,80 %) ACCOR 41.320 € (+1,00 %) WORLDLINE 0.313 € (+4,09 %) ORANGE 17.205 € (+0,03 %) ABN AMRO BANK N.V. 27.300 € (+2,02 %) EXAIL TECHNOLOGIES 126.600 € (+0,96 %) CRCAM LANGUED CCI 77.500 € (+1,31 %) OCI 3.254 € (+2,39 %) MAGNUM 12.630 € (-0,77 %) SIRIUS MEDIA 0.001 € (0,00 %) SCHNEIDER ELECTRIC 247.950 € (+2,54 %) 
ARCELORMITTAL SA 46.090 € (+1,90 %) ASR NEDERLAND 58.880 € (+1,17 %) MERSEN 22.700 € (+4,13 %) TOTALENERGIES 76.870 € (-0,44 %) AIR FRANCE -KLM 9.190 € (+2,25 %) DANONE 67.740 € (-0,85 %) AIR LIQUIDE 171.260 € (+1,24 %) CARREFOUR 15.410 € (+0,52 %) VINCI 128.800 € (+1,14 %) |
24/03/2026 07:30
Press release: Availability of the Q1 2026 aide-mémoirePress ReleaseAvailability of the Q1 2026 aide-mémoireParis, France – March 24, 2026. Sanofi announced today the availability of its Q1 2026 aidemémoire on the "Investors" page of the company's website: First quarter 2026 results (sanofi.com) Prepared each quarter, this document is intented to support financial modelling of the quarterly results. It covers non-comparable items, foreign currency impact, and share count. Sanofi's Q1 2026 results will be published on April 23, 2026. About SanofiSanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY. Media RelationsSandrine Guendoul | +33 6 25 09 14 25 | sandrine.guendoul@sanofi.com Investor RelationsThomas Kudsk Larsen | +44 75 45 51 36 93 | thomas.larsen@sanofi.com Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière